James Betti, MD
Payments from drug & device makers
What this record shows
Procept Biorobotics Corporation accounts for 68.0% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2022 at $1,331 and has fallen 82.4% since, to $234 in 2025.
Across 28 payments — averaging $64.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Procept Biorobotics Corporation$1K
- AbbVie$131
- Sumitomo Pharma America, Inc.$101
- Johnson & Johnson$78
- Tolmar, Inc.$41
- Boston Scientific$40
- plus $186 from 6 others
What the payments were for
- Travel & lodging$1,03057%
- Food & beverage$77443%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Procept Biorobotics Corporation | 7 | $1,227 |
| AbbVie | 4 | $131 |
| Sumitomo Pharma America, Inc. | 5 | $101 |
| Johnson & Johnson | 2 | $78 |
| Tolmar, Inc. | 2 | $41 |
| Boston Scientific | 1 | $40 |
| Progenics Pharmaceuticals, Inc. | 2 | $40 |
| GE HealthCare | 1 | $35 |
| Ambu Inc. | 1 | $34 |
| Urogen Pharma, Inc. | 1 | $34 |
| Pfizer | 1 | $22 |
| Telix Pharmaceuticals | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,804 in reported general payments places this provider in the 65th percentile of 61 urology providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 85 | $1,072 |
| Finasteride | 64 | $771 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 23 | $229 |
| Ciprofloxacin Hcl | 20 | $57 |
| Sildenafil Citrate | 13 | $31 |
Paid to pharmacies, not to this prescriber.
Other urology in Dover
- Shilpa LambaDover$2K
- Cormac OneillDover$2K
- Egbert BaumgartDover$1K
- Eric RaffinDover$522
- Sandy ChinDover$507
- Michael MichaelsDover$68
- Martin GrossKeene$172K
- Ramiro Madden-FuentesConcord$82K
- Jason AkermanManchester$53K
- Lori LernerLebanon$49K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.